BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $9,173,000 | -2.0% | 112,978 | +0.9% | 0.20% | +22.6% |
Q4 2019 | $9,363,000 | -4.0% | 111,973 | +0.4% | 0.16% | -14.1% |
Q3 2019 | $9,756,000 | +15.6% | 111,534 | +8.2% | 0.18% | +6.3% |
Q2 2019 | $8,441,000 | +5.3% | 103,064 | +4.5% | 0.17% | -3.9% |
Q1 2019 | $8,016,000 | +20.2% | 98,586 | -2.7% | 0.18% | +5.8% |
Q4 2018 | $6,667,000 | -14.6% | 101,294 | 0.0% | 0.17% | +48.7% |
Q3 2018 | $7,809,000 | -6.2% | 101,294 | -10.2% | 0.12% | -35.0% |
Q2 2018 | $8,327,000 | +20.1% | 112,776 | +5.8% | 0.18% | +12.7% |
Q1 2018 | $6,932,000 | -47.5% | 106,586 | -47.8% | 0.16% | -6.0% |
Q4 2017 | $13,210,000 | +9.0% | 204,356 | +5.9% | 0.17% | -7.2% |
Q3 2017 | $12,114,000 | +111.5% | 193,054 | +104.0% | 0.18% | +3.4% |
Q2 2017 | $5,729,000 | +18.1% | 94,626 | +1.2% | 0.17% | +16.0% |
Q1 2017 | $4,850,000 | +18.0% | 93,524 | +0.9% | 0.15% | +4.2% |
Q4 2016 | $4,109,000 | -5.3% | 92,680 | +1.7% | 0.14% | -6.5% |
Q3 2016 | $4,339,000 | – | 91,153 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |